Skip to content
뉴스 센터
회사 소개 채용정보 뉴스 센터 문의하기 법률 Video Hub iHope 자선 프로그램 Illumina와 비지니스 관계 구축 Investors Illumina for Startups Home

Perspectives Blog

2 min read
Illumina’s Diversity, Equity, and Inclusion Actions Earn External Recognition and Further Advance Our Culture of Care
By Dr. Lisa Toppin , Global Head of Diversity and Inclusion 2022년 1월 27일
4 min read
2021 in Genomics
By Francis deSouza , CEO
2021년 12월 30일
2 min read
When it Comes to Diversity, Awareness is No Longer Enough
By Dr. Lisa Toppin , Global Head of Diversity and Inclusion
2021년 10월 6일
2 min read
Empowering Informed Choices That Can Change Lives
By Gretchen Weightman , General Manager — Asia Pacific & Japan
2021년 6월 30일
3 min read
Reflections on a Long-term Collaboration to Drive Rapid Whole Genome Diagnostics
By Kevin Hall, Senior Director, Development 2021년 6월 16일
3 min read
Security and Scale in The Era of Genomics Data Discovery
By Susan Tousi, Chief Commercial Officer 2021년 6월 8일
3 min read
Solving for the Information Gap in Genomics Breakthroughs
By Hans Cobben, VP, Software Development 2021년 1월 28일
1 min read
MLK Day 2021: Turning Hope into Action
By Dr. Lisa Toppin, VP, Diversity and Inclusion 2021년 1월 14일
11 min read
2020 in genomics: a global pandemic and groundbreaking scientific developments
By Francis deSouza, CEO 2020년 12월 13일
4 min read
Reflecting on the Human Genome Project
By Susan Tousi, SVP, CPO 2020년 10월 26일
1 min read
More expectant parents to get access to non-invasive prenatal testing
By Dr. Phil Febbo, SVP, CMO 2020년 10월 9일
6 min read
Illumina's COVID testing service
By Dr. Phil Febbo, SVP, CMO 2020년 9월 3일
2 min read
Every voice raised against racism chips away at its power
By Francis deSouza, CEO 2020년 6월 30일
3 min read
Illumina and BlueBee: Unlocking the full potential of genomic insights
By Susan Tousi, SVP, CPO 2020년 6월 18일
2 min read
Illumina receives first FDA emergency use authorization for a sequencing based COVID-19 diagnostic test
By Susan Tousi, SVP, CPO 2020년 6월 9일
3 min read
The role of genomics in the COVID-19 pandemic, today and in the future
By Dr. Phil Febbo, SVP, CMO 2020년 6월 8일
2 min read
Standing up and speaking out for equality and justice
By Susan Tousi, SVP, CPO 2020년 6월 3일
4 min read
Something to roar about
By Susan Tousi, SVP, CPO 2020년 5월 19일
2 min read
DNA Day in the time of COVID-19
By Francis deSouza, CEO 2020년 4월 25일
2 min read
Delivering world-class solutions to combat COVID-19
By Susan Tousi, SVP, CPO 2020년 4월 16일
5 min read
How sequencing-based surveillance helps fight COVID-19
By Dr. Phil Febbo, SVP, CMO 2020년 3월 31일
2 min read
Why You Should Care about Rare Disease Day
By Francis deSouza, CEO 2020년 2월 24일
3 min read
Helping the heroes on the front lines of the SARS-CoV-2 battle
By Francis deSouza, CEO 2020년 2월 18일
2 min read
How sequencing helps solve the "unknown" of novel viral outbreaks
By Francis deSouza, CEO 2020년 2월 13일
4 min read
Partnerships catalyze patient access to genomic testing
By Dr. Phil Febbo, SVP, CMO 2020년 1월 13일
5 min read
The power and promise of liquid biopsies
By Dr. Phil Febbo, SVP, CMO 2019년 11월 6일
5 min read
The complex world of pan-cancer biomarkers
By Dr. Phil Febbo, SVP, CMO 2019년 9월 26일

Driving innovation for a healthy future

In the News

날짜 논문 제목
2023. 9. 22. MedCity News How Genome Sequencing Can Broaden the Scope of Newborn Screening
2023. 9. 22. CareNet Cancer gene panel testing, more, faster/Illumina
2023. 9. 20. Harvard Botswana lab known for identifying Omicron variant receives new recognition
View All Illumina News
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

정확한 번역을 제공하고자 합당한 노력을 기울였으나, 자동 번역은 완벽하지 않으며, 그 목적 또한 원문을 대체하기 위함이 아닙니다. 공식 콘텐츠는 영문 버전의 원문 콘텐츠임을 참고 부탁드립니다.
Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/ko-kr/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.